TREZONOM Trademark
Trademark Overview
On Thursday, January 18, 2018, a trademark application was filed for TREZONOM with the United States Patent and Trademark Office. The USPTO has given the TREZONOM trademark a serial number of 79228433. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, September 21, 2022. This trademark is owned by Novartis AG. The TREZONOM trademark is filed in the Pharmaceutical Products category with the following description:
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system relat...
General Information
| Serial Number | 79228433 |
| Word Mark | TREZONOM |
| Filing Date | Thursday, January 18, 2018 |
| Status | 404 - IR CANCELLED - US REGISTRATION CANCELLED |
| Status Date | Wednesday, September 21, 2022 |
| Registration Number | 5548037 |
| Registration Date | Tuesday, August 28, 2018 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 12, 2018 |
Trademark Statements
| Goods and Services | Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | H - NOT AVAILABLE |
| Class Status Date | Wednesday, September 21, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Novartis AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | CH |
| Party Name | Novartis AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | CH |
| Party Name | Novartis AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | CH |
Trademark Events
| Event Date | Event Description |
| Monday, April 17, 2023 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
| Monday, April 17, 2023 | DEATH OF INTERNATIONAL REGISTRATION |
| Friday, October 19, 2018 | NOTIFICATION PROCESSED BY IB |
| Saturday, September 29, 2018 | FINAL DISPOSITION NOTICE SENT TO IB |
| Saturday, September 29, 2018 | FINAL DISPOSITION PROCESSED |
| Thursday, September 27, 2018 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB |
| Tuesday, August 28, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, June 12, 2018 | PUBLISHED FOR OPPOSITION |
| Friday, June 8, 2018 | NOTIFICATION PROCESSED BY IB |
| Wednesday, May 23, 2018 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, May 23, 2018 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, May 23, 2018 | NOTICE OF PUBLICATION |
| Thursday, May 10, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, April 27, 2018 | ASSIGNED TO EXAMINER |
| Friday, March 16, 2018 | APPLICATION FILING RECEIPT MAILED |
| Monday, March 12, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, March 9, 2018 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Thursday, March 8, 2018 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB |
